Invesco’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-29,416
| Closed | -$4.45M | – | 4107 |
|
2022
Q3 | $4.45M | Sell |
29,416
-46,097
| -61% | -$6.97M | ﹤0.01% | 2288 |
|
2022
Q2 | $11M | Sell |
75,513
-72,419
| -49% | -$10.6M | ﹤0.01% | 1777 |
|
2022
Q1 | $17.5M | Sell |
147,932
-77,433
| -34% | -$9.18M | ﹤0.01% | 1587 |
|
2021
Q4 | $31.1M | Buy |
225,365
+79,404
| +54% | +$10.9M | 0.01% | 1272 |
|
2021
Q3 | $20.3M | Buy |
145,961
+66,154
| +83% | +$9.19M | 0.01% | 1556 |
|
2021
Q2 | $7.75M | Buy |
79,807
+66,845
| +516% | +$6.49M | ﹤0.01% | 2210 |
|
2021
Q1 | $886K | Buy |
12,962
+2,604
| +25% | +$178K | ﹤0.01% | 3080 |
|
2020
Q4 | $888K | Buy |
10,358
+7,030
| +211% | +$603K | ﹤0.01% | 2968 |
|
2020
Q3 | $217K | Sell |
3,328
-12,302
| -79% | -$802K | ﹤0.01% | 3404 |
|
2020
Q2 | $1.14M | Buy |
+15,630
| New | +$1.14M | ﹤0.01% | 2734 |
|
2020
Q1 | – | Sell |
-252,670
| Closed | -$13.8M | – | 3778 |
|
2019
Q4 | $13.8M | Sell |
252,670
-8,469
| -3% | -$461K | ﹤0.01% | 1593 |
|
2019
Q3 | $10.9M | Buy |
261,139
+51,706
| +25% | +$2.16M | ﹤0.01% | 1696 |
|
2019
Q2 | $9.17M | Buy |
209,433
+20,312
| +11% | +$889K | ﹤0.01% | 1803 |
|
2019
Q1 | $9.73M | Sell |
189,121
-19,920
| -10% | -$1.03M | ﹤0.01% | 1587 |
|
2018
Q4 | $7.73M | Buy |
+209,041
| New | +$7.73M | ﹤0.01% | 1674 |
|
2018
Q1 | – | Sell |
-27,723
| Closed | -$748K | – | 3831 |
|
2017
Q4 | $748K | Buy |
+27,723
| New | +$748K | ﹤0.01% | 3140 |
|